FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Dr. med. Veronika Bahlinger
List of publications:
BibTeX-Download
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie
Institute of Pathology
Publications
(48)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) (2019)
Eckstein M, Hartmann A, Strissel P, Strick R, Wach S, Taubert H, Wullich B, et al.
Conference contribution
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019)
Weyerer V, Weisser R, Moskalev E, Haller F, Stoehr R, Eckstein M, Zinnall U, et al.
Journal article
Large nested variant of urothelial carcinoma: a prime example of a FGFR3-mutated, luminal tumour (2019)
Weyerer V, Eckstein M, Comperat E, Juette H, Allory Y, Stoehr R, Wullich B, et al.
Conference contribution
Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2019)
Eckstein M, Strissel P, Pfannstiel C, Chiappinelli K, Sikic D, Wach S, Taubert H, et al.
Conference contribution
The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes (2019)
Pfannstiel C, Strissel P, Chiappinelli KB, Sikic D, Wach S, Wirtz RM, Wullweber A, et al.
Journal article
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019)
Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al.
Journal article
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype (2018)
Zinnall U, Weyerer V, Compérat E, Camparo P, Gaisa NT, Knuechel-Clarke R, Perren A, et al.
Journal article
Urothelial Bladder Cancer: An Update on Molecular Pathology with Clinical Implications (2017)
Bertz S, Eckstein M, Stoehr R, Weyerer V, Hartmann A
Journal article
‹
1
...
3
4
5
›